NDRA - ENDRA Life Sciences Inc logo

NDRA

ENDRA Life Sciences Inc

Rev โ€”top 1%5Y
Hold

ENDRA Life Sciences Inc. develops thermo-acoustic enhanced ultrasound technology that generates high-contrast images for clinical diagnostics. Its applications include treatment for non-alcoholic fatty liver disease, tissue composition, and vascular imaging.

โš•๏ธ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago โ†’$1today

Score Overview

1 Year
Scoreโ€”
Net Growth38.93%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth40.07%
Net Trend60%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
All Time
Score
Net Growth-30.69%
Net Trend50%
Net Income Consistency
Rev Growth-100.00%
Rev TrendNever
Revenue Consistency

See the full market ranking โ†’

ENDRA Life Sciences Inc fundamental performance

Across ENDRA Life Sciences Inc's full reported history, from 2017 to 2025, revenue declined from $ 351.62K to $ 0.00 and net income went from -$ 5M to -$ 7M. Revenue increased in 0% of the years measured; net income in 50%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 4.47โ€”
1 Year2025-08-12
$ 4.186.94%
5 Years2021-08-12
$ 3.08K-99.85%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 0.00-$ 7M$ 762.37K
2024$ 0.00-$ 11M$ 3M
2023$ 0.00-$ 10M$ 2M
2022$ 0.00-$ 13M$ 4M
2021$ 0.00-$ 11M$ 9M
2020$ 0.00-$ 11M$ 7M
2019$ 0.00-$ 13M$ 6M
2018$ 6.17K-$ 9M$ 6M
IPO2017$ 351.62K-$ 5M$ 5M

Explore beyond NDRA

You're looking at ENDRA Life Sciences Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies